Suminat 25 Tablet
By Suminat
Rx
1 Tablet in a Strip

Composition
Sumatriptan(25mg)

Manufacturer - Sun Pharmaceutical Industries Ltd
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135

Expires on or after
September, 2026

liver
Suminat 25 Tablet should be used with caution in individuals who have liver disease. It may be necessary to adjust the dosage of Suminat 25 Tablet in these patients. It is advisable to consult your doctor before using this medication if you have any liver issues. However, the use of Suminat 25 Tablet is not recommended in patients with severe liver disease. It is important to consider your liver health before starting this medication to ensure safety and effectiveness.

kidney
Consult your doctor for guidance on the use of Suminat 25 Tablet in patients with kidney disease. Limited information is available on its safety in such cases.

alcohol
Suminat 25 Tablet can lead to increased drowsiness when taken with alcohol.

driving
Suminat 25 Tablet may reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Suminat 25 Tablet may not be safe to use during pregnancy. Limited human studies suggest potential risks, and animal studies show harmful effects on the baby. Your doctor will consider benefits and risks before prescribing it. Consult your doctor.

breastfeeding
Suminat 25 Tablet is considered safe to use during breastfeeding. Research shows that the drug does not transfer to breastmilk in harmful quantities, posing minimal risk to the baby.
Habit Forming | No |
Chemical Class | Tryptamines Derivative |
Therapeutic Class | - |
Action Class | Triptans (5HT 1B/1D Agonist) |
₹41.35
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024